BNP Paribas Financial Markets
MRTX

BNP Paribas Financial Markets’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-55,977
Closed -$3.29M – 4310
2023
Q4 		$3.29M Buy
55,977
+1,167
+2% +$65.6K ﹤0.01% 1660
2023
Q3 		$2.39M Buy
54,810
+16,736
+44% +$598K ﹤0.01% 1768
2023
Q2 		$1.38M Sell
38,074
-27,561
-42% -$1.14M ﹤0.01% 1992
2023
Q1 		$2.44M Sell
65,635
-285,912
-81% -$12.9M ﹤0.01% 1684
2022
Q4 		$15.9M Buy
351,547
+289,019
+462% +$18.7M 0.02% 764
2022
Q3 		$4.37M Buy
62,528
+57,763
+1,212% +$4.27M 0.01% 1442
2022
Q2 		$320K Sell
4,765
-22,382
-82% -$1.42M ﹤0.01% 2884
2022
Q1 		$2.23M Sell
27,147
-14,101
-34% -$1.44M ﹤0.01% 1748
2021
Q4 		$6.05M Buy
41,248
+40,100
+3,493% +$6.23M 0.01% 1232
2021
Q3 		$203K Buy
1,148
+497
+76% +$80K ﹤0.01% 3033
2021
Q2 		$105K Sell
651
-4,896
-88% -$786K ﹤0.01% 3024
2021
Q1 		$950K Sell
5,547
-1,837
-25% -$364K ﹤0.01% 2161
2020
Q4 		$1.62M Sell
7,384
-1,387
-16% -$300K ﹤0.01% 1723
2020
Q3 		$1.46M Buy
8,771
+4,966
+131% +$680K ﹤0.01% 1639
2020
Q2 		$434K Sell
3,805
-12,270
-76% -$1.19M ﹤0.01% 2161
2020
Q1 		$1.24M Buy
16,075
+12,014
+296% +$1.08M ﹤0.01% 1779
2019
Q4 		$523K Sell
4,061
-863
-18% -$83.2K ﹤0.01% 2424
2019
Q3 		$384K Buy
4,924
+1,772
+56% +$166K ﹤0.01% 2358
2019
Q2 		$325K Sell
3,152
-1,680
-35% -$131K ﹤0.01% 2293
2019
Q1 		$354K Buy
+4,832
New +$329K ﹤0.01% 2329
2018
Q4 		– Sell
-592
Closed -$27.9K – 4459
2018
Q3 		$27.9K Hold
592
– – ﹤0.01% 3282
2018
Q2 		$29.2K Buy
+592
New +$22.4K ﹤0.01% 3339
2017
Q4 		– Sell
-2
Closed -$23 – 4324
2017
Q3 		$23 Hold
2
– – ﹤0.01% 4186
2017
Q2 		$7 Sell
2
-466
-100% -$1.78K ﹤0.01% 4242
2017
Q1 		$2.43K Sell
468
-290
-38% -$1.59K ﹤0.01% 3488
2016
Q4 		$3.6K Sell
758
-143
-16% -$778 ﹤0.01% 3809
2016
Q3 		$5.96K Buy
901
+361
+67% +$1.92K ﹤0.01% 3349
2016
Q2 		$2.95K Buy
+540
New +$8.61K ﹤0.01% 3416
2016
Q1 		– Sell
-2,268
Closed -$71.7K – 3158
2015
Q4 		$71.7K Buy
2,268
+194
+9% +$6.85K ﹤0.01% 2554
2015
Q3 		$71.4K Buy
2,074
+1,245
+150% +$37.6K ﹤0.01% 2617
2015
Q2 		$26.1K Buy
829
+631
+319% +$18.6K ﹤0.01% 2877
2015
Q1 		$5.8K Buy
+198
New +$4.64K ﹤0.01% 3065
2014
Q4 		– Sell
-120
Closed -$2.1K – 3361
2014
Q3 		$2.1K Buy
+120
New +$2.24K ﹤0.01% 3938

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's MRTX Position: Q1 2024 in Review

BNP Paribas Financial Markets sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 55,977 shares — an estimated $3.29M sold.

BNP Paribas Financial Markets first reported a position in MRTX in Q3 2014 and held it in 33 quarters. The position peaked at $15.9M in Q4 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • BNP Paribas Financial Markets reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 55,977 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.29M.
  • BNP Paribas Financial Markets first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2014 and held it in 33 quarters.
  • BNP Paribas Financial Markets's Mirati Therapeutics, Inc. Common Stock position peaked at $15.9M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2024, filed 1 May 2024.